Literature DB >> 14633132

Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.

Manuel T Velasquez1, Sam J Bhathena, Tedine Ranich, Arnold M Schwartz, David E Kardon, Ali A Ali, Christian C Haudenschild, Carl T Hansen.   

Abstract

BACKGROUND: Evidence is emerging that varying the type or source of dietary protein intake can have beneficial effects on chronic renal disease. Consumption of soybean and soy-based food products, as the source of plant protein, can retard the development and progression of chronic renal disease. We studied the obese spontaneously hypertensive/NIH-corpulent (SHR/N-cp) rat, a model of obesity and type II diabetes mellitus that consistently develops nephropathy resembling diabetic nephropathy. We specifically sought to determine whether changing the source of protein intake from animal protein, casein, to plant protein in the form of either soy protein concentrate or flaxseed protein in the diet has a different impact on renal function and nephropathy in this model.
METHODS: Male obese SHR/N-cp rats were randomly assigned to one of three diets containing either 20% casein, 20% soy protein concentrate, or 20% flaxseed meal. Except for the protein source, all three diets were identical and contained similar amounts of protein, fat, carbohydrates, minerals, and vitamins. All animals were maintained on these diets for 6 months. At the end of the study, blood sampling and 24-hour urine collections were performed for renal functional measurements, and the kidneys were harvested and examined for histologic evaluation.
RESULTS: All three groups had similar amounts of food intake and body weight gain and exhibited fasting hyperglycemia and hyperinsulinemia. Plasma glucose levels did not differ among the three groups, but plasma insulin concentration was significantly lower in rats fed flaxseed meal than those fed either casein or soy protein concentrate. Mean plasma creatinine, creatinine clearance, and urinary urea excretion also did not differ significantly between the three groups. By contrast, urinary protein excretion was significantly lower (P < 0.01) in rats fed flaxseed than in rats fed either casein or soy protein concentrate. Morphologic analysis of renal structural lesions showed that the percentage of abnormal glomeruli with mesangial expansion and the tubulointerstitial score (an index of severity of tubulointerstitial damage) were significantly reduced in rats fed flaxmeal compared to those fed casein or soy protein concentrate.
CONCLUSION: We conclude that dietary protein substitution with flaxseed meal reduces proteinuria and glomerular and tubulointerstitial lesions in obese SHR/N-cp rats and that flaxseed meal is more effective than soy protein in reducing proteinuria and renal histologic abnormalities in this model. The reduction in proteinuria and renal injury was independent of the amount of protein intake and glycemic control. Which dietary component(s) present in flaxseed meal is (are) responsible for the renal protective effect remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633132     DOI: 10.1046/j.1523-1755.2003.00329.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid.

Authors:  Delfin Rodriguez-Leyva; Chantal M C Dupasquier; Richelle McCullough; Grant N Pierce
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

3.  Dietary avocado oil supplementation attenuates the alterations induced by type I diabetes and oxidative stress in electron transfer at the complex II-complex III segment of the electron transport chain in rat kidney mitochondria.

Authors:  Omar Ortiz-Avila; Carlos Alberto Sámano-García; Elizabeth Calderón-Cortés; Ismael H Pérez-Hernández; Ricardo Mejía-Zepeda; Alain R Rodríguez-Orozco; Alfredo Saavedra-Molina; Christian Cortés-Rojo
Journal:  J Bioenerg Biomembr       Date:  2013-02-27       Impact factor: 2.945

4.  Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.

Authors:  Nivedita M Jangale; Prasad P Devarshi; Sneha B Bansode; Mahesh J Kulkarni; Abhay M Harsulkar
Journal:  J Physiol Biochem       Date:  2016-04-05       Impact factor: 4.158

5.  Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2006-12       Impact factor: 1.646

6.  Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design.

Authors:  Yeong Rhee; Ardith Brunt
Journal:  Nutr J       Date:  2011-05-09       Impact factor: 3.271

7.  Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats.

Authors:  Abhijit Ghadge; Abhay Harsulkar; Manjiri Karandikar; Vijaya Pandit; Aniket Kuvalekar
Journal:  Genes Nutr       Date:  2016-03-17       Impact factor: 5.523

8.  Flaxseed Lignans and Polyphenols Enhanced Activity in Streptozotocin-Induced Diabetic Rats.

Authors:  Dan Draganescu; Calin Andritoiu; Doina Hritcu; Gianina Dodi; Marcel Ionel Popa
Journal:  Biology (Basel)       Date:  2021-01-11

Review 9.  Biomedical features of flaxseed against different pathologic situations: A narrative review.

Authors:  Babak Ebrahimi; Zohreh Nazmara; Negar Hassanzadeh; Atousa Yarahmadi; Neda Ghaffari; Fatemeh Hassani; Amirreza Liaghat; Leila Noori; Gholamreza Hassanzadeh
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.